NASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for SHFS yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Reduce net losses significantly | Net losses narrowed from -$51.66M to -$1.78M over the same period. | Improving | net loss worsens beyond -$3M next quarter | Net income: $-1.513M FY2026-Q2; GAAP. Published target: net loss no worse than -$1.78M next quarter. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 7, 2026-1,513,235 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative growth and execution story, not a durable compounder today. The long-term thesis is on watch: recent performance is weak, earnings quality is fragile, and management execution is volatile.
SHFS is described as cheap versus peers, while the expectations gap is negative, suggesting expectations are already subdued. The evidence does not show that all of the company’s execution and operating risks are reflected in the valuation.
Near term, the risk of another earnings miss is elevated, following misses in recent quarters. Loan program income and deposits have grown, but quarterly expenses rose year over year and reported revenue remained limited; new retirement services show early traction but have not been separately quantified. Recent delisting-related and unregistered equity-sale events add to the high-risk picture.
Over the next one to three years, the thesis hinges on whether deposit and lending growth can translate into stronger revenue and better cost discipline. Early retirement-service adoption may help, but its financial contribution is not yet clear. Sector momentum could support the business backdrop if major financial companies continue to report strong results, while weaker guidance or rate cuts could weigh on the sector.
SHFS has some signs of operating growth, but weak financial performance, fragile earnings quality, and high risk leave the multi-year view dependent on clearer execution. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Cash from operations improved by $1.7M, showing progress managing cash flow. |
| Broken |
| cash flow falls below -$2M next quarter |
Cash from operations: $-2.483B FY2026-Q2; GAAP. Published target: cash from operations >= -$1.1M next quarter. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 7, 2026-2,482,806,276 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Improve operating income to near break-even | SHF Holdings improved operating income from -$7.89M in 2024-Q4 to -$1.76M in 2026-Q1. | Intact | operating income falls below -$3.5M next quarter | Operating income: $-1.026M FY2026-Q2; GAAP. Published target: >= -$1.76M operating income next quarter. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 7, 2026-1,026,354 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stabilize and grow revenue | A primary condition in SHF HOLDINGS INC's published investment case. The stated target is halt revenue decline; revenue >= $2.0M next quarter. | Improving | revenue falls below $1.8M next quarter | Revenue: $1.935M FY2026-Q2; GAAP. Published target: halt revenue decline; revenue >= $2.0M next quarter. The target does not explicitly identify fiscal versus calendar quarters. Aug 7, 20261,934,740 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.